IP Library › Granted Patent US 8,244,360
Granted Patent B2
US 8,244,360 · App. 11/374,793 · Granted Aug 14, 2012

Regional therapies for treatment of pain

Assignee: Medtronic, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,244,360
App. No.
11/374,793
Granted
Aug 14, 2012
Kind
B2
Abstract

Systems and methods for coordinated delivery of a therapeutic agent and low (less than about 20 Hz) and high (greater than about 50 Hz) frequency stimulation therapy are described. The systems include a control unit for coordinating therapy delivery between an infusion device and a pulse generator, such that a therapeutic agent is administered at a predetermined time relative to application of either low frequency or high frequency stimulation. For example, the control unit may instruct the infusion device to deliver therapeutic agent at a predetermined time prior to delivery of low frequency stimulation. Systems that include more than one infusion device or an infusion pump capable of delivering more than one therapeutic agent are also described.

Claims (32)

1. A system comprising:

a pulse generator configured to alternate between generation of a first electrical signal and generation of a second electrical signal;

a first infusion device configured to deliver a first therapeutic agent at a first rate at a first predetermined time that is a first predetermined time interval before or after a time when the pulse generator switches from generation of the first signal to generation of the second signal; and

a control unit configured to coordinate the delivery of the first therapeutic agent at the first rate from the first infusion device with the switch from the generation of the first signal to the generation of the second signal.

2. The system of claim 1 , wherein the control unit provides information to the infusion device regarding when the pulse generator switches from generation of the first signal to generation of the second signal.

3. The infusion system of claim 1 , wherein the control unit instructs the first infusion device when to deliver the first therapeutic agent.

4. The system of claim 1 , wherein the control unit is an external programmer unit.

5. The system of claim 4 , wherein the external programmer unit provides instructions regarding therapy delivery to both the pulse generator and the first infusion device.

6. The system of claim 5 , wherein the external programmer informs the first infusion device regarding when the pulse generator will switch from generation of the first signal to generation of the second signal at the time the programmer provides instructions regarding therapy to the first infusion device.

7. The system of claim 1 , wherein the control unit and the first infusion device are housed within a single housing.

8. The system of claim 7 , wherein the control unit is configured to communicate wirelessly with the pulse generator.

9. The system of claim 1 , wherein the pulse generator and the control unit are configured to communicate wirelessly.

10. The system of claim 9 , wherein the first infusion device and the control unit are configured to communicate wirelessly.

11. The system of claim 1 , wherein the first infusion device and the control unit are configured to communicate wirelessly.

12. The system of claim 1 , wherein the first infusion device delivers the first therapeutic agent at a second rate at a second predetermined time that is a second predetermined time interval before or after the time when the pulse generator switches from generation of the first signal to generation of the second signal, and wherein the control unit is further configured to coordinate the delivery of the first therapeutic agent at the second rate from the first infusion device with the switch from the generation of the first signal to the generation of the second signal.

13. The system of claim 1 , wherein the first infusion device delivers the first therapeutic agent at a second rate at a second predetermined time that is a second predetermined time interval before or after a time when the pulse generator switches from generation of the second signal to generation of the first signal, and wherein the control unit is further configured to coordinate the delivery of the first therapeutic agent at the second rate from the first infusion device with the switch from the generation of the second signal to the generation of the first signal.

14. The system of claim 1 , further comprising a second infusion device that delivers a second therapeutic agent at a second predetermined time that is a second predetermined time interval before or after the time when the pulse generator switches from generation of the first signal to generation of the second signal,

wherein the control unit is further configured to coordinate the delivery of the second therapeutic agent from the second infusion device with the switch from the generation of the first signal to the generation of the second signal, and

wherein the second predetermined time is the same or different than the first predetermined time.

15. The system of claim 1 , further comprising a second infusion device that delivers a second therapeutic agent at a second predetermined time that is a second predetermined time interval before or after a time when the pulse generator switches from generation of the second signal to generation of the first signal, wherein the control unit is further configured to coordinate the delivery of the second therapeutic agent from the second infusion device with the switch from the generation of the second signal to the generation of the first signal.

16. The system of claim 1 , further comprising a first reservoir and a second reservoir operably coupled to the first infusion device, the first reservoir being configured to house the first therapeutic agent.

17. The system of claim 16 , wherein the second reservoir is configured to house a second therapeutic agent.

18. The system of claim 17 , wherein the first infusion device delivers the second therapeutic agent at a second predetermined time that is a second predetermined time interval before or after the time when the pulse generator switches from generation of the first signal to generation of the second signal,

wherein the control unit is further configured to coordinate the delivery of the second therapeutic agent from the first infusion device with the switch from the generation of the first signal to the generation of the second signal, and

wherein the first predetermined time and the second predetermined time is the same or different.

19. The system of claim 17 , wherein the first infusion device delivers the second therapeutic agent at a second predetermined time that is a second predetermined time interval before or after a time when the pulse generator switches from generation of the second signal to generation of the first signal, wherein the control unit is further configured to coordinate the delivery of the second therapeutic agent from the first infusion device with the switch from the generation of the second signal to the generation of the first signal.

20. A system comprising:

a pulse generator configured to alternate between generation of a first electrical signal and generation of a second electrical signal; and

an infusion device configured to deliver a first therapeutic agent at a predetermined time that is a predetermined time interval before or after a time when the pulse generator switches from generation of the first signal to generation of the second signal.

21. A method comprising:

identifying whether a first predetermined electrical signal is being generated by an implantable pulse generator via a control unit; and

instructing an infusion device to deliver a therapeutic agent at a rate if the predetermined electrical signal is being generated via the control unit, wherein the control unit is separate from the implantable pulse generator and the infusion device.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2006
From: HERUTH, MR. KENNETH T.; LENT, MR. MARK S.; SINGHAL, MS. RUCHIKA; SCHENDEL, MR. MICHAEL J.; KING, MR. GARY W.
To: MEDTRONIC, INC.
Reel/Frame 017554/0759 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2006
From: HERUTH, MR. KENNETH T.; LENT, MR. MARK S.; SINGHAL, MS. RUCHIKA; SCHENDEL, MR. MICHAEL J.
To: MEDTRONIC, INC.
Reel/Frame 017533/0740 →
Continuity (3)
Provisional Application 60700627 · Jul 19, 2005
Provisional Application 60761823 · Jan 25, 2006
Related Publication 20070039625A1 · Feb 22, 2007